How We Grade GLP-1 Providers: The Verdict Score Explained

Every provider on this site gets a single number out of 100: the Verdict Score. It exists because the GLP-1 telehealth market is engineered to be confusing — teaser prices, vague pharmacies, "all 50 states" claims that quietly aren't. The Verdict Score is our attempt to replace that noise with one honest, comparable figure. Here is exactly how it is built.

The rule that makes it worth reading

We apply the identical rubric to providers we earn a commission from and providers we don't — and we disclose partner status on every card. Affiliate status never adjusts a score. A ranking that flatters every provider is worthless; we rank the weak ones low and state the reasons. Facts (pricing, states served, verification) come from each provider's public disclosures at last review; the weighted score is our editorial judgment. It is never sold. The permanent version of this rubric lives at our methodology page.

The six factors and their weights

**Real-world results — 20%.** Does the provider's protocol mirror what actually produced results in the pivotal trials — adequate dosing, proper titration, and the molecules that work? Only semaglutide and tirzepatide have that record: roughly 15% mean weight loss for semaglutide in STEP-1¹ and about 20–21% at tirzepatide's top dose in SURMOUNT-1². A watered-down protocol or an unproven "alternative" is marked down here.

**Price honesty — 20%.** Not just the number, but whether it's truthful: no first-month teaser that silently triples, no hidden membership, lab, or consult fees stacked on later. An honest flat rate beats a lower sticker with a step-up.

**Prescriber access — 18%.** How many states served, speed to a real prescriber and first dose, and whether a licensed clinician — not a form — stands behind the prescription.

**Formulary choice — 15%.** Breadth: both molecules, brand-name (FDA-approved) availability where possible, and oral routes for the needle-averse. Options only count when they match what patients actually want to do.

**Cancellation fairness — 14%.** How easily you can pause, switch, or quit — versus contracts, forced auto-ship, and deliberately painful exits.

**Member support — 13%.** Ongoing care quality: side-effect and titration guidance, responsiveness, and whether support survives past the first shipment.

Why verification sits underneath everything

Compounded GLP-1 medications are not FDA-approved, and the FDA does not verify their safety, effectiveness, or quality³. So the pharmacy behind a provider is not a footnote — it colors the results, price-honesty, and access factors alike. A LegitScript-certified or 503B-backed operation earns trust a low sticker cannot buy. We unpack this fully in is compounded semaglutide legit and safe.

From factors to a grade

The six sub-scores combine, by the weights above, into the 0–100 Verdict Score, which maps to a letter grade for quick scanning. A 94 is not a rounding error away from an 84 — it reflects a provider that is honest on price, verified, nationwide, and supportive across the board, versus one that stumbles on two or three factors.

What the score is not

It is not a medical recommendation, and it is not a substitute for talking to a clinician about your history. It is not vendor-supplied — no provider writes or buys its number. And it is not static: telehealth pricing changes constantly, so entries are dated and re-checked, and you should confirm the current price on the provider's own site before deciding.

Use it

Start from the ranked reviews and read the score next to the reasons. If you want the decision framework instead of the leaderboard, the provider checklist walks the same factors in the order you'd apply them yourself.